{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:02:06Z","timestamp":1790276526332,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thebonejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.bone.2014.04.016","type":"journal-article","created":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T03:20:46Z","timestamp":1398309646000},"page":"222-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"special_numbering":"C","title":["68Ga DOTA-TATE PET\/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT\/CT"],"prefix":"10.1016","volume":"64","author":[{"given":"Stefan","family":"Breer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Brunkhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Timo","family":"Beil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kersten","family":"Peldschus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Heiland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Klutmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Barvencik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozef","family":"Zustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-Friedrich","family":"Gratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Amling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bone.2014.04.016_bb0005","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00402-008-0808-2","article-title":"Oncogenic osteomalacia: two case reports with surprisingly different outcomes","volume":"129","author":"Seijas","year":"2009","journal-title":"Arch Orthop Trauma Surg"},{"issue":"6","key":"10.1016\/j.bone.2014.04.016_bb0010","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.tripleo.2009.07.005","article-title":"Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature","volume":"108","author":"Woo","year":"2009","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"2","key":"10.1016\/j.bone.2014.04.016_bb0015","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1212\/01.wnl.0000225057.56863.33","article-title":"Oncogenic osteomalacia: muscular weakness and multiple fractures","volume":"67","author":"Ladha","year":"2006","journal-title":"Neurology"},{"issue":"23","key":"10.1016\/j.bone.2014.04.016_bb0020","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1056\/NEJM199406093302310","article-title":"Tumor-induced osteomalacia \u2014 unveiling a new hormone","volume":"330","author":"Econs","year":"1994","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.bone.2014.04.016_bb0025","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1586\/eem.09.27","article-title":"Tumor-induced osteomalacia","volume":"4","author":"Farrow","year":"2009","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.bone.2014.04.016_bb0030","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0002-9343(84)90112-8","article-title":"Oncogenous osteomalacia. Review of the world literature of 42 cases and report of two new cases","volume":"77","author":"Ryan","year":"1984","journal-title":"Am J Med"},{"issue":"9308","key":"10.1016\/j.bone.2014.04.016_bb0035","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(02)07846-7","article-title":"Localisation of mesenchymal tumours by somatostatin receptor imaging","volume":"359","author":"de Beur SM","year":"2002","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.bone.2014.04.016_bb0040","doi-asserted-by":"crossref","first-page":"F1170","DOI":"10.1152\/ajprenal.00072.2005","article-title":"\u201cPhosphatonins\u201d and the regulation of phosphorus homeostasis","volume":"289","author":"Berndt","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"issue":"11","key":"10.1016\/j.bone.2014.04.016_bb0045","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.bone.2014.04.016_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.bone.2014.04.016_bb0055","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","article-title":"Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature","volume":"27","author":"Jiang","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.bone.2014.04.016_bb0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1750-3639.2004.tb00505.x","article-title":"August 2003: 47-year-old female with a 7-year history of osteomalacia and hypophosphatemia","volume":"14","author":"Reis-Filho","year":"2004","journal-title":"Brain Pathol"},{"issue":"12","key":"10.1016\/j.bone.2014.04.016_bb0065","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1210\/jc.2011-1757","article-title":"The importance of whole body imaging in tumor-induced osteomalacia","volume":"96","author":"Chong","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.bone.2014.04.016_bb0070","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/jbmr.1881","article-title":"Tumor localization and biochemical response to cure in tumor-induced osteomalacia","volume":"28","author":"Chong","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.bone.2014.04.016_bb0075","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.humpath.2013.07.016","article-title":"Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A)","volume":"44","author":"Houang","year":"2013","journal-title":"Hum Pathol"},{"issue":"11","key":"10.1016\/j.bone.2014.04.016_bb0080","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/RLU.0b013e31818866bf","article-title":"Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia","volume":"33","author":"Duet","year":"2008","journal-title":"Clin Nucl Med"},{"issue":"2","key":"10.1016\/j.bone.2014.04.016_bb0085","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00003072-199902000-00016","article-title":"Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia","volume":"24","author":"Nguyen","year":"1999","journal-title":"Clin Nucl Med"},{"issue":"4","key":"10.1016\/j.bone.2014.04.016_bb0090","first-page":"493","article-title":"A case of oncogenic osteomalacia detected by 111In-pentetreotide total body scan","volume":"21","author":"Casari","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.bone.2014.04.016_bb0095","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bone.2006.07.027","article-title":"A case of oncogenic osteomalacia with preoperative secondary hyperparathyroidism: description of the biochemical response of FGF23 to octreotide therapy and surgery","volume":"40","author":"Elston","year":"2007","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.bone.2014.04.016_bb0100","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00259-006-0317-x","article-title":"Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?","volume":"34","author":"Antunes","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.bone.2014.04.016_bb0105","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/jc.2012-3642","article-title":"Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET\/CT","volume":"98","author":"Clifton-Bligh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.bone.2014.04.016_bb0110","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1359\/jbmr.060909","article-title":"Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography","volume":"22","author":"Hesse","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.bone.2014.04.016_bb0115","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1007\/s00259-008-0755-8","article-title":"(68)Ga-DOTANOC PET\/CT for the detection of a mesenchymal tumor causing oncogenic osteomalacia","volume":"35","author":"von Falck","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.bone.2014.04.016_bb0120","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1210\/jc.2010-0543","article-title":"Tumor-induced hypophosphatemic rickets in an adolescent boy \u2014 clinical presentation, diagnosis, and histological findings in growth plate and muscle tissue","volume":"95","author":"Haeusler","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.bone.2014.04.016_bb0125","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/RLU.0b013e318279eb13","article-title":"Successful localization of residual culprit tumor in a case of tumor-induced osteomalacia using 68Ga-DOTANOC PET\/CT","volume":"38","author":"Naswa","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.bone.2014.04.016_bb0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-0037-1619980","article-title":"Guideline 2009 for prevention, diagnosis and therapy of osteoporosis in adults","volume":"20","author":"DVO","year":"2011","journal-title":"Osteologie"},{"issue":"8","key":"10.1016\/j.bone.2014.04.016_bb0135","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00259-004-1486-0","article-title":"68Ga-labelled DOTA-derivatised peptide ligands","volume":"31","author":"Meyer","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.bone.2014.04.016_bb0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0300-595X(72)80057-4","article-title":"Quantitative histology of metabolic bone disease","volume":"1","author":"Bordier","year":"1972","journal-title":"Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.bone.2014.04.016_bb0145","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1359\/jbmr.090728","article-title":"Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients","volume":"25","author":"Priemel","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.04.016_bb0150","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.ejrad.2013.04.006","article-title":"Effective detection of the tumors causing osteomalacia using [Tc-99m]-HYNIC-octreotide (99mTc-HYNIC-TOC) whole body scan","volume":"11","author":"Jing","year":"2013","journal-title":"Eur J Radiol"},{"issue":"10","key":"10.1016\/j.bone.2014.04.016_bb0155","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s00259-003-1255-5","article-title":"DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals","volume":"30","author":"Wild","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.bone.2014.04.016_bb0160","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2265.2001.01056.x","article-title":"Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy","volume":"54","author":"Rhee","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.bone.2014.04.016_bb0165","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/00003072-200208000-00007","article-title":"Bone and In-111 octreotide imaging in oncogenic osteomalacia: a case report","volume":"27","author":"Garcia","year":"2002","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.bone.2014.04.016_bb0170","series-title":"Imaging of tumour-induced osteomalacia using a gallium-68 labelled somatostatin analogue, BMJ Case Rep","author":"Woff","year":"2010"},{"issue":"3","key":"10.1016\/j.bone.2014.04.016_bb0175","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","article-title":"Tumor-induced osteomalacia","volume":"18","author":"Chong","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.bone.2014.04.016_bb0180","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1754-9485.2011.02327.x","article-title":"High management impact of Ga-68 DOTATATE (GaTate) PET\/CT for imaging neuroendocrine and other somatostatin expressing tumours","volume":"56","author":"Hofman","year":"2012","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.bone.2014.04.016_bb0185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/978-3-642-27994-2_18","article-title":"Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET\/CT of gastroenteropancreatic neuroendocrine tumors","volume":"194","author":"Poeppel","year":"2013","journal-title":"Recent Results Cancer Res"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214001513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214001513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T21:14:33Z","timestamp":1565385273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328214001513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":37,"alternative-id":["S8756328214001513"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2014.04.016","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"68Ga DOTA-TATE PET\/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT\/CT","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2014.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}